What does BioNexus Gene Lab Corp (BGLC) do?

BioNexus Gene Lab Corp (BGLC) is a publicly traded company in the Healthcare sector.

What sector does BGLC operate in?

BioNexus Gene Lab Corp operates in the Healthcare, specifically within the Services–Medical Laboratories industry. AlphaOS tracks cycle stage, supply-chain relationships, and investment intelligence for companies across all sectors.

Where can I find BGLC earnings analysis?

AlphaOS publishes an earnings intelligence page for BioNexus Gene Lab Corp (BGLC) covering results, guidance context, and AI-assisted analysis. See /stocks/BGLC/earnings. Content is for research and education — not investment advice.

Intelligence coverage: 60%

Basic profile, financials, and market data are shown below. Deep research is building in the background.

BGLC

BioNexus Gene Lab Corp

Healthcare · Services–Medical Laboratories

$1.30Sep 28, 2026

AI confidence 70% · prior close shown (market closed)

Investment Snapshot

Weak evidence · 1 source

Why it matters

BioNexus Gene Lab Corp shows decelerating business momentum based on AlphaOS pipeline evidence.

Why it matters: Revenue -97% YoY in Q2 FY2026.

TrajectoryDecelerating

3 signals not yet derived from pipeline evidence

Key signals

What it means for the thesis — synthesis, not a raw event feed.

Revenue -97% YoY in Q2 FY2026

Pipeline evidence · 0d ago

BGLC's AlphaOS Signals

Upgrade to Pro for validated historical pattern analysis on BGLC.

Create free account

Free accounts see more of this; Premium sees all of it.

Latest earnings · Q2 2026

Full BGLC earnings analysis

Reported figures for BioNexus Gene Lab Corp — research only, not investment advice.

Revenue YoY: -100.0%

Latest Intelligence

Updated September 30, 2026

What happened recently for BioNexus Gene Lab Corp (BGLC) — events, not interpretation.

Event: Reported Q2 2026 revenue -100% YoY.
Also: Last session September 28, 2026 at $1.3.
Source: Q2 2026 earnings

Research & analysis only — not investment advice.

Building company intelligence…

BioNexus Gene Lab Corp (BGLC)

Healthcare · Services–Medical Laboratories

Investment Snapshot above is the primary AlphaOS analysis for BioNexus Gene Lab Corp — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.

Key facts

Sector:: Healthcare
Industry:: Services–Medical Laboratories
Market cap:: $3.81M
Revenue:: $76,160

BGLC earnings analysis

Research & analysis only — not investment advice. Price, charts, and filings are above.

Connected intelligence

Follow BioNexus Gene Lab Corp through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.

Connected companies and research pages from the AlphaOS knowledge graph.